1. Home
  2. PCRX vs SPTN Comparison

PCRX vs SPTN Comparison

Compare PCRX & SPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • SPTN
  • Stock Information
  • Founded
  • PCRX 2006
  • SPTN 1917
  • Country
  • PCRX United States
  • SPTN United States
  • Employees
  • PCRX N/A
  • SPTN N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • SPTN Food Distributors
  • Sector
  • PCRX Health Care
  • SPTN Consumer Discretionary
  • Exchange
  • PCRX Nasdaq
  • SPTN Nasdaq
  • Market Cap
  • PCRX 604.7M
  • SPTN 618.4M
  • IPO Year
  • PCRX 2011
  • SPTN N/A
  • Fundamental
  • Price
  • PCRX $20.72
  • SPTN $17.74
  • Analyst Decision
  • PCRX Buy
  • SPTN Hold
  • Analyst Count
  • PCRX 10
  • SPTN 1
  • Target Price
  • PCRX $27.40
  • SPTN $20.00
  • AVG Volume (30 Days)
  • PCRX 751.0K
  • SPTN 328.9K
  • Earning Date
  • PCRX 02-27-2025
  • SPTN 02-13-2025
  • Dividend Yield
  • PCRX N/A
  • SPTN 4.96%
  • EPS Growth
  • PCRX N/A
  • SPTN 9.92
  • EPS
  • PCRX N/A
  • SPTN 1.33
  • Revenue
  • PCRX $694,957,000.00
  • SPTN $9,532,883,000.00
  • Revenue This Year
  • PCRX $4.83
  • SPTN N/A
  • Revenue Next Year
  • PCRX $2.16
  • SPTN $2.15
  • P/E Ratio
  • PCRX N/A
  • SPTN $13.16
  • Revenue Growth
  • PCRX 4.40
  • SPTN N/A
  • 52 Week Low
  • PCRX $11.16
  • SPTN $17.30
  • 52 Week High
  • PCRX $34.01
  • SPTN $23.00
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 63.53
  • SPTN 36.04
  • Support Level
  • PCRX $18.18
  • SPTN $17.30
  • Resistance Level
  • PCRX $22.36
  • SPTN $18.65
  • Average True Range (ATR)
  • PCRX 0.94
  • SPTN 0.48
  • MACD
  • PCRX 0.12
  • SPTN -0.06
  • Stochastic Oscillator
  • PCRX 60.86
  • SPTN 21.26

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About SPTN SpartanNash Company

SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.

Share on Social Networks: